Trials / Completed
CompletedNCT01075594
Study of Undertreatment of Patients With Dyslipidemia in Bulgaria
Centralized Pan-Bulgarian Survey on the Undertreatment of Hypercholesterolemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish the proportion of Bulgarian patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Fourth Joint European Task Force guidelines.
Conditions
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2010-02-25
- Last updated
- 2010-09-10
Locations
15 sites across 1 country: Bulgaria
Source: ClinicalTrials.gov record NCT01075594. Inclusion in this directory is not an endorsement.